Fulgent Genetics (FLGT) Shares Outstanding (Diluted Average) (2016 - 2026)

Fulgent Genetics has disclosed Shares Outstanding (Diluted Average) across 11 years of filings, most recently posting $30.9 million for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $30.9 million, changed 0.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $30.9 million (changed 0.16% YoY), and the FY2022 annual result was $31.0 million, changed 0.04% from the prior year.
• Shares Outstanding (Diluted Average) came in at $30.9 million for Q1 2026 at Fulgent Genetics, up from $30.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $31.2 million in Q1 2022 to a low of $29.5 million in Q1 2023.
• The 5-year median for Shares Outstanding (Diluted Average) is $30.6 million (2025), against an average of $30.5 million.
• Across the five-year window, Shares Outstanding (Diluted Average) fell 5.45% in 2023 and climbed 3.57% in 2025, its largest moves.
• Fulgent Genetics' Shares Outstanding (Diluted Average) stood at $31.0 million in 2022, then decreased by 3.07% to $30.0 million in 2023, then climbed by 0.27% to $30.1 million in 2024, then advanced by 2.04% to $30.7 million in 2025, then rose by 0.56% to $30.9 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $30.9 million (Q1 2026), $30.7 million (Q3 2025), and $30.5 million (Q2 2025), per Business Quant data.